top of page

News & Updates

Filter by:

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

News & Updates

2023年2月22日

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Read More
Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer
Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

News & Updates

2022年10月23日

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

Read More
Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022
Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

News & Updates

2022年10月18日

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

Read More
Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey
Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

News & Updates

2022年9月26日

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

Read More
Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer
Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis

News & Updates

2022年7月28日

Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis

Read More
Local Study Demonstrates Synergies of Using Blood-based Liquid Biopsies to complement Tissue Biopsies for Lung Cancer Diagnosis
Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy

News & Updates

2022年7月14日

Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy

Read More
Lucence Presents Data at 2022 World Conference on Lung Cancer (WCLC) Supporting Utility of Amplicon-Based Liquid Biopsy
Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting

News & Updates

2022年5月31日

Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting

Read More
Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay for Lung Cancer at 2022 ASCO Annual Meeting
Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay

News & Updates

2022年5月19日

Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay

Read More
Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay
Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA

News & Updates

2022年1月10日

Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA

Read More
Lucence’s LiquidHALLMARK Liquid Biopsy Assay Expands to Include cfRNA

1

/

5

bottom of page